Wörwag Pharma Slovensko
Pharmaceutical products for patients, pharmacies and healthcare professionals in Slovakia
Highlights
- ProfitableFY2025 net profit €632k · RÚZ
- New on EvolcAdded 2026-11-18
About Wörwag Pharma Slovensko
Wörwag Pharma Slovensko distributes prescription medicines, over-the-counter products and food supplements focused on areas including the nervous system, immunity, mobility and diabetes. Its products are available through pharmacies.
The company supports patients and provides healthcare professionals in hospitals and medical practices with expertise on vitamins, minerals and trace elements for preventing and treating lifestyle-related diseases. It is led by managing director Lucia Frzonová and her team.
Wörwag Pharma Slovensko s. r. o. was founded in 2020 and is based in Bratislava. It is part of an international pharmaceutical group active in more than 35 markets.
Product: Prescription medicines, over-the-counter products and food supplements sold through pharmacies.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €23.6M | €23.2M | €21.8M | €22.1M | €22.6M |
| Growth | +2% | +6% | −1% | −2% | — |
| EBITDA | €977k | €1.0M | €475k | €700k | €883k |
| Operating profit | €924k | €910k | €312k | €549k | €744k |
| Net profit | €632k | €714k | €200k | €378k | €372k |
| Net margin | 2.7% | 3.1% | 0.9% | 1.7% | 1.6% |
| Personnel costs | €3.1M | €3.0M | €2.7M | €2.6M | €2.9M |
| Total assets | €5.9M | €9.0M | €6.9M | €5.1M | €6.2M |
| Cash | €1.4M | €2.3M | €1.1M | €928k | €1.1M |
| Liabilities | €5.0M | €8.1M | €6.5M | €4.6M | €5.9M |
| Equity | €866k | €948k | €424k | €525k | €296k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts Wörwag Pharma Slovensko signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
3 contracts with 1 buyer · €11k
| Contracts | Value | |
|---|---|---|
| Univerzita Komenského v Bratislave - Farmaceutická fakulta | 2 | €9k |
Open public tenders for Wörwag Pharma Slovensko →
Latest contracts
Jobs at Wörwag Pharma Slovensko
Leadership
- Lucia Frzonová · generálna riaditeľkaSource: company website
More biotech & pharma companies
Zentiva
Manufacturer of generic and branded prescription and OTC medicines supplied to patients and partners across Europe4Health
Intermediary connecting manufacturers, suppliers and buyers of healthcare, pharma and wellbeing products in EuropeYoung companyAlmirall
Slovak subsidiary of Almirall supplying dermatology prescription and OTC medicines to doctors, pharmacies and clinicsYoung companyGrowingamphora
Glass ampoules, type 1 pharmaceutical packaging, for drug manufacturers in Slovakia and the regionYoung companyProfitableGrowingARTMED
Pharmacovigilance and drug registration services for pharmaceutical companies in SlovakiaProfitableNew on EvolcAUREPHARM
Exclusive EU distributor of London-made Biomelius Ltd dietary supplements in capsulesYoung company
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- UsercentricsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
